Preoperative assessment of adults undergoing elective noncardiac surgery: Updated guidelines from the European Society of Anaesthesiology and Intensive Care

M Lamperti, CS Romero, F Guarracino… - European Journal of …, 2025 - journals.lww.com
BACKGROUND When considering whether a patient is fit for surgery, a comprehensive
patient assessment represents the first step for an anaesthetist to evaluate the risks …

Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care: Second update 2022

S Kietaibl, A Ahmed, A Afshari… - European Journal of …, 2023 - journals.lww.com
Guidelines Management of severe peri-operative bleeding: Guidelines from the European
Society of Anaesthesiology and Intensive Care

[HTML][HTML] The road to implementation of pharmacokinetic-guided dosing of factor replacement therapy in hemophilia and allied bleeding disorders. Identifying …

TMHJ Goedhart, A Janssen, RAA Mathôt, MH Cnossen… - Blood Reviews, 2023 - Elsevier
Clinical guidelines and expert groups recommend the use of pharmacokinetic (PK)-guided
dosing of factor replacement therapy for the treatment of bleeding disorders, especially for …

Deep compartment models: a deep learning approach for the reliable prediction of time‐series data in pharmacokinetic modeling

A Janssen, FWG Leebeek, MH Cnossen… - CPT …, 2022 - Wiley Online Library
Nonlinear mixed effect (NLME) models are the gold standard for the analysis of patient
response following drug exposure. However, these types of models are complex and time …

[HTML][HTML] SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders

MH Cnossen, I van Moort, SH Reitsma… - Journal of Thrombosis …, 2022 - Elsevier
Background Treatment choices for individual patients with an inborn bleeding disorder are
increasingly challenging due to increasing options and rising costs for society. We have …

Peri‐operative desmopressin combined with pharmacokinetic‐guided factor VIII concentrate in non‐severe haemophilia A patients

LGR Romano, LM Schütte, RM van Hest, K Meijer… - …, 2024 - Wiley Online Library
Introduction Non‐severe haemophilia A patient can be treated with desmopressin or factor
VIII (FVIII) concentrate. Combining both may reduce factor consumption, but its feasibility …

A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement

A Janssen, L Smalbil, FC Bennis… - Clinical …, 2024 - Wiley Online Library
In rare diseases, such as hemophilia A, the development of accurate population
pharmacokinetic (PK) models is often hindered by the limited availability of data. Most PK …

Design of a prospective study on pharmacokinetic-guided dosing of prophylactic factor replacement in hemophilia A and B (OPTI-CLOT TARGET study)

TMHJ Goedhart, LH Bukkems, M Coppens… - TH Open, 2022 - thieme-connect.com
In resource-rich countries, almost all severe hemophilia patients receive prophylactic
replacement therapy with factor concentrates to prevent spontaneous bleeding in joints and …

On inductive biases for the robust and interpretable prediction of drug concentrations using deep compartment models

A Janssen, FC Bennis, MH Cnossen… - … of Pharmacokinetics and …, 2024 - Springer
Conventional pharmacokinetic (PK) models contain several useful inductive biases guiding
model convergence to more realistic predictions of drug concentrations. Implementing …

Mixed effect estimation in deep compartment models: Variational methods outperform first-order approximations

A Janssen, FC Bennis, MH Cnossen… - … of Pharmacokinetics and …, 2024 - Springer
This work focusses on extending the deep compartment model (DCM) framework to the
estimation of mixed-effects. By introducing random effects, model predictions can be …